Progressive B cell depletion in human MALT1 deficiency.
Agammaglobulinemia
/ diagnosis
B-Lymphocytes
/ cytology
CARD Signaling Adaptor Proteins
/ genetics
Cell Differentiation
/ genetics
Child
DNA Mutational Analysis
Guanylate Cyclase
/ genetics
Humans
Interleukin-2
/ biosynthesis
Lymphocyte Activation
/ genetics
Lymphopenia
/ diagnosis
Male
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
/ deficiency
NF-kappa B
/ metabolism
Severe Combined Immunodeficiency
/ genetics
T-Lymphocytes
/ immunology
B cell
immunodeficiency diseases
transplantation
Journal
Clinical and experimental immunology
ISSN: 1365-2249
Titre abrégé: Clin Exp Immunol
Pays: England
ID NLM: 0057202
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
16
09
2021
received:
30
04
2021
accepted:
16
09
2021
pubmed:
25
9
2021
medline:
29
12
2021
entrez:
24
9
2021
Statut:
ppublish
Résumé
Mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (MALT1)-deficiency is a rare combined immunodeficiency characterized by recurrent infections, dermatitis and enteropathy. We herein investigate the immunological profiles of our patient and previously reported children with MALT1-deficiency. A mutation analysis was performed by targeted panel sequencing for primary immunodeficiency. Lymphocyte subset, activation and B cell differentiation were analyzed by flow cytometry and t-distributed stochastic neighbor embedding. Pneumocystis pneumonia developed in a 6-month-old Japanese infant with atopic dermatitis, enteritis and growth restriction. This infant showed agammaglobulinemia without lymphopenia. At 8 years of age, the genetic diagnosis of MALT1-deficiency was confirmed on a novel homozygous mutation of c.1102G>T, p.E368X. T cell stimulation tests showed impairments in the production of interleukin-2, phosphorylation of nuclear factor kappa B (NF-κB) p65 and differentiation of B cells. In combination with the literature data, we found that the number of circulatory B cells, but not T cells, were inversely correlated with the age of patients. The hematopoietic cell transplantation (HCT) successfully reconstituted the differentiation of mature B cells and T cells. These data conceptualize that patients with complete MALT1-deficiency show aberrant differentiation and depletion of B cells. The early diagnosis and HCT lead to a cure of the disease phenotype associated with the loss-of-function mutations in human CARD11.
Identifiants
pubmed: 34559885
doi: 10.1111/cei.13662
pmc: PMC8561700
doi:
Substances chimiques
CARD Signaling Adaptor Proteins
0
IL2 protein, human
0
Interleukin-2
0
NF-kappa B
0
MALT1 protein, human
EC 3.4.22.-
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
EC 3.4.22.-
CARD11 protein, human
EC 4.6.1.2
Guanylate Cyclase
EC 4.6.1.2
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
237-247Subventions
Organisme : the Health and Labor Sciences Research grants
ID : 20FC1053
Informations de copyright
© 2021 British Society for Immunology.
Références
J Allergy Clin Immunol. 2013 Jul;132(1):151-8
pubmed: 23727036
J Clin Immunol. 2019 May;39(4):401-413
pubmed: 31037583
J Immunol. 2008 Jan 15;180(2):800-8
pubmed: 18178818
J Allergy Clin Immunol. 2018 Mar;141(3):1036-1049.e5
pubmed: 29241729
Front Immunol. 2018 Apr 27;9:909
pubmed: 29755476
Blood. 2002 Jun 1;99(11):4200-6
pubmed: 12010826
J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):378-384
pubmed: 27253662
Clin Exp Immunol. 2021 Dec;206(3):237-247
pubmed: 34559885
J Biol Chem. 2004 Apr 16;279(16):15870-6
pubmed: 14754896
Br J Dermatol. 2020 Jan;182(1):202-207
pubmed: 31049936
Clin Immunol. 2016 Mar;164:52-6
pubmed: 26812624
Br J Haematol. 2019 Oct;187(1):25-38
pubmed: 31418827
Clin Exp Immunol. 2010 Nov;162(2):271-9
pubmed: 20854328
J Hum Genet. 2016 Jun;61(6):547-53
pubmed: 26911352
Immunity. 2003 Nov;19(5):749-58
pubmed: 14614861
Eur J Immunol. 2006 Apr;36(4):810-6
pubmed: 16541472
Cell Mol Life Sci. 2021 May;78(10):4677-4701
pubmed: 33751142
J Allergy Clin Immunol. 2017 Nov;140(5):1388-1393.e8
pubmed: 28192146
Clin Immunol. 2016 Jul;168:1-5
pubmed: 27109639
Biochem Biophys Rep. 2016 Dec 23;9:146-152
pubmed: 28956000
Nat Rev Immunol. 2019 Feb;19(2):118-134
pubmed: 30467369
J Immunol. 2017 Feb 1;198(3):1066-1080
pubmed: 28031341
Front Immunol. 2018 Sep 19;9:2078
pubmed: 30283440
Front Immunol. 2019 Apr 24;10:878
pubmed: 31105700
EMBO J. 2014 Dec 1;33(23):2765-81
pubmed: 25319413
Front Pediatr. 2019 May 21;7:183
pubmed: 31231620
J Clin Immunol. 2016 Oct;36(7):656-66
pubmed: 27484504
J Allergy Clin Immunol. 2019 Apr;143(4):1482-1495
pubmed: 30170123
J Clin Immunol. 2015 Feb;35(2):135-46
pubmed: 25627829
Front Pediatr. 2020 Jan 24;7:552
pubmed: 32039114
J Immunol. 2015 Apr 15;194(8):3723-34
pubmed: 25762782
J Allergy Clin Immunol. 2010 Sep;126(3):602-10.e1-11
pubmed: 20673987
J Immunol. 2019 Dec 1;203(11):2791-2806
pubmed: 31659015
J Allergy Clin Immunol. 2014 May;133(5):1458-62, 1462.e1-7
pubmed: 24332264